Join

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

  • Barings BDC Inc. logo
    PR··Finance·
    Barings BDC, Inc. Announces Conference Call to Discuss Second Quarter 2026 Results

    Barings BDC, Inc. (NYSE:BBDC) ("Barings BDC" or the "Company") announced today that it will report its financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, after the market closes. Barings BDC, Inc. has scheduled a conference call to discuss its second quarter 2026 financial results for Thursday, August 6, 2026, at 8:30 a.m. ET. To listen to the call, please dial 877-407-8831 or 201-493-6736 approximately 10 minutes prior to the start of the call. A taped replay will be made available approximately two hours after the conclusion of the call and will remain available until August 13, 2026. To access the replay, please dial 877-660-6853 or 201-612-7415

  • Spero Therapeutics Inc. logo
    KKR & Co. Inc. logo
    PR··Health Care·
    Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

    Financing supports Phase 2 development of SP001, Spero’s first immunology drug candidate, in-licensed from Innovent Biologics Transaction unlocks immediate value from future Utebzi (tebipenem pivoxil) milestones and royalties, and positions Spero to participate in potential long-term commercial upside Spero updates its cash runway guidance into the second half of 2029 CAMBRIDGE, Mass., July 14, 2026 (GLOBE NEWSWIRE) --  Spero Therapeutics, Inc. (NASDAQ:SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced a $105 million non-recourse non-dilutive royalty financing transaction with affiliates of Healt

  • News Corporation logo
    News Corporation logo
    PR··Consumer Discretionary·
    Some Cities Are Building Their Way to Lower Rent. Others Are Falling Behind: Realtor.com June 2026 Rent Report

    New York and Boston Are Building at Their Slowest Pace Since 2019, While Florida and Columbus, Ohio Build FastestAUSTIN, Texas, July 14, 2026 /PRNewswire/ -- The median asking monthly rent across the 50 largest metros fell to $1,692 in June, down 1.5%, or $25, from a year ago. The drop marked the 35th straight month of year-over-year declines, as a multiyear multifamily construction boom continues to outpace demand nationally, according to the Realtor.com® June 2026 Rent Report. Which metros see the most relief next may hinge on where permitting and construction are happening now, and that activity is diverging sharply by market. "This didn't happen by accident. Builders spent years playing

  • CleanSpark Inc. logo
    PR··Finance·
    CleanSpark Secures Twenty-Year Lease with High-Investment Grade Global Technology Company for Data Center in Sandersville, Georgia

    Twenty-year triple-net (NNN) lease totaling $6.6 billion in contracted revenue, with up to $11.6 billion after full extension options175 MW of critical IT load with deliveries expected to begin in Q4 2027 to a high-investment-grade tenantTenant has executed a letter of intent and exclusivity arrangement covering CleanSpark's entire Texas portfolio of 885 MWLAS VEGAS, July 14, 2026 /PRNewswire/ -- CleanSpark, Inc. (NASDAQ:CLSK) ("CleanSpark" or the "Company"), a market leading data center developer, today announced it has entered into a 20-year infrastructure lease agreement, with two five-year extension options, directly with a high-investment grade, leading global technology company at its

  • Spero Therapeutics Inc. logo
    PR··Health Care·
    Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

    Under the terms of the agreement, Spero will receive exclusive global rights, excluding Greater China, to develop, research, manufacture, and commercialize IBI355 (Spero R&D code: SP001)Innovent will receive an upfront payment, and is eligible to receive development, regulatory and commercial milestone payments, totaling approximately US$1.1 billion, as well as tiered royalties on net salesSpero plans to initiate a Phase 2 trial for IBI355 in Q2 2027 in IgG4-related disease (IgG4-RD), a serious, chronic fibroinflammatory condition with significant treatment burden and limited therapeutic options Innovent plans to initiate a Phase 2 trial in China by early 2027 for Sjögren's disease (SjD), a

  • Jinxin Technology Holding Company logo
    PR··Real Estate·
    Jinxin Technology Holding Company Regains Compliance with Nasdaq's Minimum Bid Price Requirement

    SHANGHAI, July 14, 2026 /PRNewswire/ -- Jinxin Technology Holding Company ("Jinxin" or the "Company") (NASDAQ:NAMI), an innovative digital content service provider in China, today announced that on July 13, 2026, it has received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), stating that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). The matter is now closed.  As previously disclosed, on January 29, 2026, the Company received a notification letter from Nasdaq, indicating that for the 30 consecutive business days prior to that date, the closing bid price for the Compan

  • Tencent Music Entertainment Group logo
    PR··Consumer Discretionary·
    Tencent Music Entertainment Group to Report Second Quarter 2026 Financial Results on August 11, 2026

    SHENZHEN, China, July 14, 2026 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE:TME), the leading online music and audio entertainment platform in China, today announced that it will report its unaudited financial results for the second quarter of 2026 before the U.S. market opens on Tuesday, August 11, 2026. TME's management will host a Tencent Meeting Webinar on Tuesday, August 11, 2026, at 7:00 A.M. Eastern Time or 7:00 P.M. Beijing/Hong Kong Time on Tuesday, August 11, 2026, to review and discuss the Company's business and financial performance.For participants who wish to join the Tencent Meeting Webinar, please complete online registration in advance us

  • AngioDynamics Inc. logo
    PR··Health Care·
    AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

    Delivered its seventh consecutive quarter of double-digit Med Tech segment growth and positive adjusted EBITDA AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourth quarter and fiscal year 2026, which ended May 31, 2026. Fiscal Year 2026 Fourth Quarter Financial Highlights     Quarter Ended May 31, 2026   Pro Forma* YoY Growth Pro Forma* Net Sales $86.6 million   8.0% Med Tech Net

  • Personalis Inc. logo
    PR··Health Care·
    Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain

    Regulatory milestone for the NeXT Personal® Dx test enables clinical use of Personalis’ ultrasensitive MRD detection in Great BritainPersonalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced that it has achieved UKCA (United Kingdom Conformity Assessed) marking for its NeXT Personal Dx test. This critical regulatory milestone enables the clinical use of Personalis’ ultrasensitive Minimal Residual Disease (MRD) detection technology across Great Britain, encompassing England, Wales, and Scotland.The UKCA marking confirms that the NeXT Personal Dx test meets the United Kingdom's stringent safety, health, and performance standards. This achievement dem

  • Beam Global logo
    PR··Technology·
    Beam Global Announces Preliminary Second Quarter 2026 Revenue Up More Than 170% From Q1 And More Than 20% Year-Over-Year

    SAN DIEGO, July 14, 2026 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation, energy security and smart city infrastructure, today announced that preliminary, unaudited revenue for the second quarter of 2026 exceeded $8.5 million, an increase of more than 170% over first quarter and more than 20% over second quarter of 2025. These figures are preliminary and unaudited. They are estimates based on information available as of the date of this release and remain subject to change in connection with the completion of the Company's quarter-end closing procedures and the review of it

  • NextCure Inc. logo
    Akero Therapeutics Inc. logo
    PR··Health Care·
    NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

    Avere Therapeutics’ lead program, AVR-001, is a differentiated oral peptide interleukin-23 (IL-23) receptor antagonist, with Phase 1b psoriasis data supporting its potential to be rapidly developed as a convenient, once-weekly oral therapy Concurrent $320 million private investment from world-class investor syndicate ensures combined company is well-capitalized to accelerate development of AVR-001 Company’s financial runway expected to fund AVR-001 through Phase 2b readout in psoriasis, initiation of a Phase 3 trial in psoriasis, and initiation of a Phase 2b trial in ulcerative colitis Company to be led by a seasoned team of biotech executives: Andrew Cheng, MD, PhD as CEO, President, & C

  • Ouster Inc. logo
    PR··Industrials·
    Ouster Announces Date for Second Quarter 2026 Earnings Call

    Company to Report Q2 2026 Results on August 6, 2026 Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, today announced that it will report its financial results for the quarter ended June 30, 2026 after the market closes on Thursday, August 6, 2026 and host a conference call that day at 5:00 p.m. ET to discuss its results. Registration for the webcast can be completed by visiting the following website prior to, or on the day of, the conference call: https://register-conf.media-server.com/register/BI6ead86baced44176974b83a7905844fa. The webcast will be available for replay for at least 30 days after the conference call on Ouster’s

  • Spero Therapeutics Inc. logo
    PR··Health Care·
    Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

    Under the terms of the agreement, Spero will receive exclusive global rights, excluding Greater China, to develop, research, manufacture, and commercialize SP001 (IBI355) Innovent will receive an upfront payment, and is eligible to receive development, regulatory and commercial milestone payments, totaling approximately US$1.1 billion, as well as tiered royalties on net salesSpero plans to initiate a Phase 2 trial for SP001 in Q2 2027 in IgG4-related disease (IgG4-RD), a serious, chronic fibroinflammatory condition with significant treatment burden and limited therapeutic options Innovent plans to initiate a Phase 2 trial in China by early 2027 for Sjögren’s disease (SjD), a chronic autoimmu

  • KBR Inc. logo
    PR··Industrials·
    KBR’s Mission Technology Solutions Selected for Multiple-Award Advisory Contract for National Air and Space Intelligence Center

    HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE:KBR) announced its Mission Technology Solutions business has been selected for a new multiple-award, Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the National Air and Space Intelligence Center (NASIC) to advance critical intelligence missions.  The Advisory Support and Technical Requirement Administration (ASTRA) contract has an $866 million ceiling value across all awardees and supports multiple contract types for task orders over five years. The award broadens KBR’s work in delivering engineering and technical solutions, helping translate complex threat data into actionable insights across the air, space and cyber domain

  • Unity Bancorp Inc. logo
    PR··Finance·
    Unity Bancorp Reports Quarterly Earnings of $14.5 Million

    CLINTON, N.J., July 14, 2026 (GLOBE NEWSWIRE) -- Unity Bancorp, Inc. (NASDAQ:UNTY), parent company of Unity Bank, reported net income of $14.5 million, or $1.42 per diluted share, for the quarter ended June 30, 2026, compared to net income of $14.3 million, or $1.40 per diluted share for the quarter ended March 31, 2026. For the six months ended June 30, 2026, Unity Bancorp reported net income of $28.8 million, or $2.82 per diluted share, compared to net income of $28.1 million, or $2.74 per diluted share, for the six months ended June 30, 2025. James A. Hughes, CEO, commented on the financial results: "We are pleased to announce that Unity Bancorp, Inc. delivered another strong quarter,

  • Lithia Motors Inc. logo
    PR··Consumer Discretionary·
    Lithia & Driveway (LAD) Schedules Release of Second Quarter 2026 Results

    MEDFORD, Ore., July 14, 2026 (GLOBE NEWSWIRE) -- Lithia & Driveway (NYSE:LAD) today announced its second quarter 2026 results will be released before the market opens on Wednesday, July 29, 2026. A conference call to discuss the earnings results is scheduled for the same day at 10:00 a.m. Eastern Time. How to Participate The conference call may be accessed by telephone at (877) 407-8029. To listen live on our website, or for replay, visit investors.lithiadriveway.com and click on quarterly earnings. About Lithia & Driveway (LAD)Lithia & Driveway (NYSE:LAD) is the largest global automotive retailer making Auto Done Easy by providing simple, transparent, and convenient experiences through

  • Nayax Ltd. logo
    PR··Technology·
    Nayax: information security incident update

    HERZLIYA, Israel, July 14, 2026 (GLOBE NEWSWIRE) -- Further to Nayax’s announcement dated July 8, 2026, regarding a suspected information security incident, the Company provides the following update. The Company's system review and technical remediation activities have been completed, and the Company's systems have been cleared and based on its investigation to date, confirmed to be free of unauthorized access. The Company's production environment and core systems have not been impacted. The Company's business operations continue as normal, without disruption or impact on our operations. As the Company's investigation progressed, and while the precise scope and complete contents of the e

  • Information Services Group Inc. logo
    PR··Consumer Discretionary·
    Nordic Firms Seek Green, Sovereign AI Infrastructure

    Renewable power, heat reuse and local data requirements are reshaping private and hybrid cloud choices, ISG Provider Lens® report says Nordic enterprises are adopting private and hybrid cloud infrastructure that combines AI-ready capacity, local residency and low-carbon operations as high-performance workloads and geopolitical risk reshape IT strategies, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The 2026 ISG Provider Lens® Private/Hybrid Cloud — Data Center Services report for the Nordics finds that the region is evolving from a hosting destination into a backbone for

  • SemiLEDS Corporation logo
    PR··Technology·
    SemiLEDs Reports Third Quarter Fiscal Year 2026 Financial Results

    SemiLEDs Corporation (NASDAQ:LEDS), "SemiLEDs" or the "Company," a developer and manufacturer of LED chips and LED components, today announced its financial results for the third quarter of fiscal year 2026, ended May 31, 2026. Revenue for the third quarter of fiscal 2026 was $9.1 million, compared to $1.1 million in the second quarter of fiscal 2026. GAAP net income attributable to SemiLEDs stockholders for the third quarter of fiscal 2026 was $1.5 million, or $0.18 per diluted share, compared to a net loss of $603 thousand, or $(0.07) per diluted share, in the second quarter of fiscal 2026. GAAP gross margin for the third quarter of fiscal 2026 was 27%, compared to 1% for the second q

  • GCM Grosvenor Inc. logo
    PR··Finance·
    I Squared Capital to Sell Minority Stake in TIP Group, a Leading Pan-European Equipment Leasing Platform, to IMCO and GCM Grosvenor

    I Squared Capital ("I Squared"), a leading independent global infrastructure investor, today announced it has entered into a definitive agreement to sell a 25% minority interest in TIP Group ("TIP" or the "Company"), one of Europe’s leading transportation equipment leasing and services platforms, to Investment Management Corporation of Ontario ("IMCO") and GCM Grosvenor. Headquartered in Amsterdam, TIP is one of Europe's largest trailer leasing and equipment services companies, operating a fleet of approximately 90,000 trailers, trucks, and specialised equipment with over 130 service locations in 17 countries. The Company provides integrated leasing, rental, maintenance and repair, digita